Credit Suisse’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.26M | Buy |
125,381
+4,135
| +3% | +$38.5K | ﹤0.01% | 2126 |
|
|
2023
Q4 | $1.13M | Sell |
121,246
-8,261
| -6% | -$85.4K | ﹤0.01% | 2261 |
|
|
2023
Q3 | $1.65M | Sell |
129,507
-2,242
| -2% | -$30.8K | ﹤0.01% | 1951 |
|
|
2023
Q2 | $1.87M | Buy |
131,749
+32,253
| +32% | +$453K | ﹤0.01% | 1958 |
|
|
2023
Q1 | $1.48M | Buy |
99,496
+2,403
| +2% | +$36.4K | ﹤0.01% | 2059 |
|
|
2022
Q4 | $1.44M | Buy |
97,093
+21,420
| +28% | +$350K | ﹤0.01% | 2087 |
|
|
2022
Q3 | $1.25M | Buy |
75,673
+2,642
| +4% | +$53.2K | ﹤0.01% | 2165 |
|
|
2022
Q2 | $1.53M | Buy |
73,031
+1,132
| +2% | +$23.1K | ﹤0.01% | 2088 |
|
|
2022
Q1 | $1.69M | Buy |
71,899
+1,813
| +3% | +$44.4K | ﹤0.01% | 2200 |
|
|
2021
Q4 | $1.91M | Buy |
70,086
+2,645
| +4% | +$70.8K | ﹤0.01% | 2825 |
|
|
2021
Q3 | $1.92M | Sell |
67,441
-17,200
| -20% | -$524K | ﹤0.01% | 2851 |
|
|
2021
Q2 | $2.57M | Sell |
84,641
-16,877
| -17% | -$498K | ﹤0.01% | 2652 |
|
|
2021
Q1 | $2.59M | Buy |
101,518
+5,540
| +6% | +$142K | ﹤0.01% | 2621 |
|
|
2020
Q4 | $2.35M | Buy |
95,978
+13,695
| +17% | +$257K | ﹤0.01% | 2698 |
|
|
2020
Q3 | $1.34M | Sell |
82,283
-9,301
| -10% | -$173K | ﹤0.01% | 2723 |
|
|
2020
Q2 | $1.57M | Sell |
91,584
-17,529
| -16% | -$260K | ﹤0.01% | 2575 |
|
|
2020
Q1 | $1.27M | Buy |
109,113
+15,237
| +16% | +$314K | ﹤0.01% | 2461 |
|
|
2019
Q4 | $2.61M | Buy |
93,876
+37,679
| +67% | +$945K | ﹤0.01% | 2398 |
|
|
2019
Q3 | $1.27M | Sell |
56,197
-4,088
| -7% | -$93.2K | ﹤0.01% | 2834 |
|
|
2019
Q2 | $1.52M | Sell |
60,285
-15,680
| -21% | -$421K | ﹤0.01% | 2643 |
|
|
2019
Q1 | $2.06M | Sell |
75,965
-719,287
| -90% | -$24.1M | ﹤0.01% | 2348 |
|
|
2018
Q4 | $26.2M | Sell |
795,252
-1,657,778
| -68% | -$66.7M | 0.03% | 643 |
|
|
2018
Q3 | $114M | Sell |
2,453,030
-850,258
| -26% | -$39M | 0.1% | 185 |
|
|
2018
Q2 | $143M | Buy |
3,303,288
+18,108
| +0.6% | +$868K | 0.14% | 125 |
|
|
2018
Q1 | $183M | Sell |
3,285,180
-40,502
| -1% | -$2.22M | 0.17% | 108 |
|
|
2017
Q4 | $178M | Sell |
3,325,682
-1,252,472
| -27% | -$59.1M | 0.16% | 111 |
|
|
2017
Q3 | $197M | Buy |
4,578,154
+4,452,705
| +3,549% | +$212M | 0.19% | 88 |
|
|
2017
Q2 | $7.57M | Sell |
125,449
-213,540
| -63% | -$12.7M | 0.01% | 1367 |
|
|
2017
Q1 | $23.5M | Sell |
338,989
-4,188
| -1% | -$291K | 0.02% | 744 |
|
|
2016
Q4 | $22.9M | Sell |
343,177
-165,139
| -32% | -$10.7M | 0.02% | 739 |
|
|
2016
Q3 | $33.7M | Buy |
508,316
+156,321
| +44% | +$10.7M | 0.03% | 600 |
|
|
2016
Q2 | $25.5M | Buy |
351,995
+18,994
| +6% | +$1.31M | 0.03% | 649 |
|
|
2016
Q1 | $21.5M | Buy |
333,001
+129,024
| +63% | +$8.56M | 0.03% | 691 |
|
|
2015
Q4 | $14.6M | Buy |
203,977
+23,054
| +13% | +$1.71M | 0.02% | 951 |
|
|
2015
Q3 | $13.9M | Sell |
180,923
-140,091
| -44% | -$11.3M | 0.02% | 931 |
|
|
2015
Q2 | $23.8M | Buy |
321,014
+49,088
| +18% | +$3.53M | 0.02% | 745 |
|
|
2015
Q1 | $19.7M | Buy |
271,926
+103,055
| +61% | +$7.16M | 0.02% | 824 |
|
|
2014
Q4 | $11.2M | Sell |
168,871
-10,653
| -6% | -$650K | 0.01% | 1201 |
|
|
2014
Q3 | $9.84M | Sell |
179,524
-102,362
| -36% | -$5.81M | 0.01% | 1297 |
|
|
2014
Q2 | $16.4M | Buy |
281,886
+49,481
| +21% | +$2.91M | 0.01% | 1059 |
|
|
2014
Q1 | $14.4M | Sell |
232,405
-91,006
| -28% | -$5.29M | 0.01% | 1017 |
|
|
2013
Q4 | $17.3M | Sell |
323,411
-37,843
| -10% | -$2.03M | 0.02% | 903 |
|
|
2013
Q3 | $18.1M | Buy |
361,254
+10,860
| +3% | +$530K | 0.02% | 787 |
|
|
2013
Q2 | $16M | Buy |
+350,394
| New | +$15.7M | 0.02% | 867 |
|
Other funds holding MD
Credit Suisse's MD Position: Q1 2024 in Review
Credit Suisse increased its Pediatrix Medical (MD) stake by 3.4% in Q1 2024, buying an estimated $38.5K and bringing the position to 125,381 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.
Credit Suisse first reported a position in MD in Q2 2013 and has held it in 44 quarters since. The position peaked at $197M in Q3 2017. 213 funds tracked by Wall St. Rank hold MD as of Q1 2024.
- Credit Suisse held 125,381 shares of Pediatrix Medical worth $1.26M as of Q1 2024.
- Credit Suisse bought 4,135 Pediatrix Medical shares in Q1 2024, an estimated $38.5K.
- Pediatrix Medical made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2126 holding.
- Credit Suisse first reported a position in Pediatrix Medical in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Pediatrix Medical position peaked at $197M in Q3 2017.
- 213 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.